Proliferation Inhibition of Human Cancer Cells in Combined Use of Electroporation with Attenuated Diphtheria Toxin

Cancer Biotherapy and Radiopharmaceuticals

Volumn 18, Issue 5, 2003, Pages 803-810

  Mashiba, Harukazu ^a   Matsunaga, Keiko ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Attenuated diphtheria toxin; Electroporation; Human cancer

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA TOXIN; FORMALDEHYDE;

ARTICLE; BINDING ASSAY; CANCER CELL; CANCER CELL CULTURE; CELL ASSAY; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPATHOGENIC EFFECT; ELECTRIC POTENTIAL; ELECTROPORATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MITOSIS INHIBITION; PANCREAS CANCER; POROSITY; PRIORITY JOURNAL; TARGET CELL; TECHNIQUE;

EID: 0242497010     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497803770418346     Document Type: Article

References (21)

1. Chazal M, Benchimol D, Baque P, et al. Treatment of hepatic metastases of colorectal cancer by electrochemotherapy: An experimental study in the rat. Surgery 1998;124:536.
2. Heller L, Pottinger C, Jaroszeski MJ, et al. In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity. Melanoma Res 2000;10:577.
3. Jaroszeski MJ, Coppola D, Pottinger C, et al. Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy. Eur J Cancer 2001;37:422.
4. Domenge C, Orlowski S, Luboinski B, et al. Antitumor electrochemotherapy: New advances in the clinical protocol. Cancer 1996;77:956.
5. Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996;77:964.
6. Glass LF, Jaroszeski M, Gilbert R, et al. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 1997;37:596.
7. Sersa G, Stabuc B, Cemazar M, et al. Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients. Clin Cancer Res 2000;6:863.
8. Mashiba H, Ozaki Y, Ikuno S, Matsunaga K. Augmentation of antiproliferative and antitumor effect on human cancer cells in combined use of electroporation with a plant toxin, saporin. Cancer Biother Radiopharm 2001;16:495.
9. Schnell R, Staak O, Borchmann P, et al. A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma. Clin Cancer Res 2002;8:1779.
10. Candiani C, Tommasi M, Fracasso G, et al. Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin. Life Sci 2001;69:335.
11. Selbo PK, Sivam G, Fodstad O, et al. Photochemical intemalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin. Int J Cancer 2000;87:853.
12. Rosenblum MG, Marks JW, Cheung LH. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin. Cancer Chemother Pharmacol 1999;44:343.
13. Ricci C, Polito L, Nanni P, et al. HER/erbB receptors as therapeutic targets of immunotoxins in human rhabdomyosarcoma cells. J Immunother 2002;25:314.
14. Engebraaten O, Sivam G, Juell S, Fodstad O. Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats. Int J Cancer 2000;88:970.
15. Wang L, Liu B, Schmidt M, et al. Antitumor effect of an HER2-specific antibody-toxin fusion protein on human prostate cancer cells. Prostate 2001;47:21.
16. Vallera DA, Jin N, Baldrica JM, et al. Retroviral immunotoxin gene therapy of acute myelogenous leukemia in mice using cytotoxic T cells transduced with an interleukin 4/diphtheria toxin gene. Cancer Res 2000;60:976.
17. Rozemuller H, Terpstra W, Rombouts EJ, et al. GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF. Leukemia 1998;12:1962.
18. Petre J, Pizza M, Nencioni L, et al. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization. Dev Biol Stand 1996;87:125.
19. Rittenberg MB, Pinney CT Jr, Iglewski BH. Antigenic relationships on the diphtheria toxin molecule: Antitoxin versus antitoxoid. Infect Immun 1976;14:122.
20. Vingerhoeds MH, Steerenberg PA, Hendriks JJ, et al. Targeted delivery of diphtheria toxin via immunoliposomes: Efficient antitumor activity in the presence of inactivating anti-diphtheria toxin antibodies. FEBS Lett 1996;395:245.
21. Mastrobattista E, Koning GA, van Bloois L, et al. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J Biol Chem 2002;277:27,135.